Fny Investment Advisers, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Fny Investment Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 10, 2023	SELL	$7.0 - $16.87 $1.84 Million - $4.44 Million	-263,322 Reduced 99.91%	250 $3,000
Q3 2022 Oct 19, 2022	BUY	$144.95 - $152.29 $36.8 Million - $38.6 Million	253,692 Added 2567.73%	263,572 $1.66 Million
Q2 2022 Jul 12, 2022	BUY	$83.14 - $145.99 $821,423 - $1.44 Million	9,880 New	9,880 $1.44 Million
Q3 2019 Oct 25, 2019	SELL	$37.38 - $49.47 $844,788 - $1.12 Million	-22,600 Closed	0 $0
Q2 2019 Jul 24, 2019	BUY	$39.79 - $67.01 $899,254 - $1.51 Million	22,600 New	22,600 $989,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.